Showing results (381-390 of 651) with videos related to

Sort By:
Pageof 66
American Heart Journal|May 9, 2025
Effect of once-weekly subcutaneous semaglutide on arterial inflammation in people with type 2 diabetes and cardiovascular disease using PET-MRI: Primary results of a randomized, double-blind, placebo-controlled trialStefan James, Andreas Dyreborg Christoffersen, Jens-Peter David, et al.
Diabetes|July 10, 2021
The Low-Expression Variant of FABP4 Is Associated With Cardiovascular Disease in Type 1 DiabetesEmma H Dahlström, Jani Saksi, Carol Forsblom, et al.
The Lancet. Diabetes & Endocrinology|November 11, 2018
Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trialDick de Zeeuw, Ronny W Renfurm, George Bakris, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 26, 2026
A Hierarchical Composite Endpoint for Chronic Kidney Disease Progression in Patients with Focal Segmental GlomerulosclerosisHiddo J L Heerspink, Dustin J Little, Samvel B Gasparyan, et al.
American Journal of Nephrology|March 31, 2026
Effect of finerenone treatment discontinuation on kidney and cardiovascular outcomes: a FIDELITY analysisAjay K Singh, Stefan D Anker, Bertram Pitt, et al.
Diabetes, Obesity & Metabolism|March 31, 2026
Albuminuria and Carotid Atherosclerosis in Type 1 Diabetes Evaluated Using Three-Dimensional Vascular UltrasoundLuis F Ferreira-Divino, Christina G Poulsen, Viktor Rotbain Curovic, et al.
Journal of Hypertension|August 4, 2015
Plasma proteomics classifiers improve risk prediction for renal disease in patients with hypertension or type 2 diabetesMichelle J Pena, Joachim Jankowski, Georg Heinze, et al.
Diabetes, Obesity & Metabolism|August 13, 2025
Metabolomic risk predictors of diabetic foot complications: A longitudinal observational study in type 1 diabetesJonas A Andersen, Tommi Suvitaival, Kajetan Trošt, et al.
Cardiovascular Diabetology|April 27, 2018
Novel risk genes identified in a genome-wide association study for coronary artery disease in patients with type 1 diabetesRomain Charmet, Seamus Duffy, Sareh Keshavarzi, et al.
Diabetes Care|July 3, 2025
Effect of SGLT2 Inhibition on Glucosuria During a Hyperglycemic Clamp in HNF1A-MODY (MODY3) and Type 2 DiabetesHenrik Maagensen, Johanne S Jensen, Stine O Høyerup, et al.
Pageof 66